Kiniksa Pharmaceuticals International, plc
KNSA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001730430
In the last 90 days, Kiniksa Pharmaceuticals International, plc insiders filed 0 open-market purchases and 2 sales; 267 institutions reported holding it in 13F filings for Q2 2026, worth $2.99B in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Kiniksa Pharmaceuticals International, plc as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 189
- +15 vs. Q1 2025
- Shares held
- 39.9M
- −4.84K (0.0%) vs. Q1 2025
- Total value
- $1.10B
- +$217.4M (+24.6%) vs. Q1 2025
- New holders
- 48
- 65 more added
- Sold out
- 33
- 63 more reduced
2 institutions that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KNSA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 267 | $2.99B |
| Q1 2026 | 228 | $2.18B |
| Q4 2025 | 224 | $1.77B |
| Q3 2025 | 204 | $1.59B |
| Q2 2025 | 189 | $1.10B |
| Q1 2025 | 176 | $889.4M |
| Q4 2024 | 160 | $773.1M |
| Q3 2024 | 176 | $991.2M |
| Q2 2024 | 133 | $659.4M |
| Q1 2024 | 154 | $768.1M |
| Q4 2023 | 142 | $600.4M |
| Q3 2023 | 134 | $605.8M |
| Q2 2023 | 127 | $447.7M |
| Q1 2023 | 132 | $339.6M |
| Q4 2022 | 125 | $450.0M |
| Q3 2022 | 104 | $383.2M |
| Q2 2022 | 92 | $290.5M |
| Q1 2022 | 96 | $306.0M |
| Q4 2021 | 103 | $346.4M |
| Q3 2021 | 101 | $332.0M |
| Q2 2021 | 102 | $402.0M |
| Q1 2021 | 105 | $537.6M |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Kiniksa Pharmaceuticals International, plc; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| MetLife Investment Management | 0 | $0 | 0.00% | −22,695−100.0% | Sold out |
| Campbell & CO Investment Adviser LLC | 0 | $0 | 0.00% | −22,036−100.0% | Sold out |
| Fred Alger Management, LLC | 0 | $0 | 0.00% | −21,823−100.0% | Sold out |
| Allianz Asset Management GmbH | 0 | $0 | 0.00% | −17,500−100.0% | Sold out |
| State of Wyoming | 0 | $0 | 0.00% | −17,064−100.0% | Sold out |
| Price T Rowe Associates Inc | 0 | $0 | 0.00% | −16,755−100.0% | Sold out |
| Corebridge Financial, Inc. | 0 | $0 | 0.00% | −15,979−100.0% | Sold out |
| Manufacturers Life Insurance Company, The | 0 | $0 | 0.00% | −13,919−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −13,373−100.0% | Sold out |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −12,676−100.0% | Sold out |
| BIT Capital GmbH | 0 | $0 | 0.00% | −11,878−100.0% | Sold out |
| ProShare Advisors LLC | 0 | $0 | 0.00% | −10,225−100.0% | Sold out |
| State Board of Administration of Florida Retirement System | 0 | $0 | 0.00% | −9,127−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −9,121−100.0% | Sold out |
| Police & Firemen's Retirement System of New Jersey | 0 | $0 | 0.00% | −8,625−100.0% | Sold out |
| Ameritas Investment Partners, Inc. | 0 | $0 | 0.00% | −3,649−100.0% | Sold out |
| Amalgamated Bank | 0 | $0 | 0.00% | −1,328−100.0% | Sold out |
| Coldstream Capital Management Inc | 0 | $0 | 0.00% | −496−100.0% | Sold out |
| Macquarie Group Ltd | 0 | $0 | 0.00% | −509−100.0% | Sold out |
| Sterling Capital Management LLC | 0 | $0 | 0.00% | −44−100.0% | Sold out |
| Larson Financial Group LLC | 0 | $0 | 0.00% | −33−100.0% | Sold out |
| Hughes Financial Services, LLC | 0 | $0 | 0.00% | −24−100.0% | Sold out |
| Kodai Capital Management LP | – | – | – | – | Not filed |
| Lindbrook Capital, LLC | – | – | – | – | Not filed |